Home Blog Page 5

This Chipmaker Is Creating A Whole New Kind of AI – And They Could Pay You While You Wait Out the Coronavirus

This Chipmaker Is Creating A Whole New Kind of AI – And They Could Pay You While You Wait Out the Coronavirus

A recent advance that largely flew under Wall Street’s radar says a lot about why artificial intelligence (AI) is set to have a $15.7 trillion impact on the global economy.

Known as “neuromorphic computing,” the cutting-edge method gets closer to simulating the way human brains work.

The system could redefine high-performance computing because it operates at lightning speeds and barely sips energy.

Right now, fast and robust graphics processors are the main power behind AI.

That’s set to change because the new chips work especially well for AI-powered neural networks used in speech and pattern recognition, and computer vision.

In fact, Gartner says neuromorphic chips upon which the platform is based, are set to have a huge impact. They could become the predominant computing for AI by 2025.

Today, I’m going to reveal the chipmaker behind this breakthrough and show you why it is well-positioned to handle the coronavirus panic and should at least be on your watchlist…



Transforming Productivity

Now then, I believe giving computers and mobile devices better and more human-like insights is an unstoppable trend.

And I’m not the only one who thinks so. A recent study by Accenture found that AI could boost productivity by 40% by 2035.

Even better, the study found that in 12 advanced economies with combined GDPs of roughly $61 trillion, AI can double economic growth over the period.

For most investors, AI sounds a bit vague. So, let me take a moment to boil it all down for you.

AI basically falls into two main categories – narrow and general. In its narrow form, an AI platform learns a specific task. Think of self-driving cars and virtual assistants like Siri from Apple Inc. (AAPL).

As you might imagine, general AI is more robust. It’s a flexible form of intelligence and can be applied to solve any problem.

General AI works by using a mix of machine learning, neural networks, deep learning, and natural language processing.

For today’s chat, I want to focus on neural networks because this aspect of AI will benefit greatly from the next-gen chip breakthrough we’ve been talking about.

Simply stated, they are made up of interconnected layers of computing units (neurons) that feed data into each other. They are designed to simulate the way our brains process information and are applied to tasks too complex for humans to perform.

Just take a look at Agrobot. The privately held firm is using an AI-powered autonomous harvester to pick strawberries. Agrobot employs a 3D camera to help it pick the ripest fruit without damaging it, something humans find very difficult to achieve for hours on end.

Then there’s 12 Sigma Technologies. It’s developing an AI system to aid with diagnosing lung cancer, a deadly form of the disease with a five-year survival rate of just 17%.

Lung cancer is so fatal because doctors can only see larger nodules growing on the lungs. But 12 Sigma is learning to sift through hundreds of images from CAT scans to develop an early warning system.

Now you know why the recent announcement from Intel Corp. (INTC) about its AI breakthrough is so important.

A New AI Standard



Indeed, Intel has unveiled a computing system with the brainpower of a small animal. It’s built on neuromorphic chips, so-called because the processors are designed to work like an actual brain.

Dubbed Pohoiki Springs, the Intel system is comprised of 768 Loihi neuromorphic chips inside a frame the size of five regular computer servers. These processing chips pack 130,000 artificial neurons and 130 million synapses.

When used in Pohoiki Springs, the number of neurons is boosted to an astounding 100 million (likening it to that of a small mammal).

Gartner predicts that neuromorphic chips will displace graphics processing units (GPUs) by 2025. This is a big deal because GPUs are one of the main computer chips used for AI – especially neural networks.

Unlike traditional computers, which have to process information in one area and then send it along to another area for storage, Loihi is able to perform both functions in the same spot.

Cutting down the distance that data has to travel saves time and energy.

Intel says that the Loihi chips are “1,000 times faster and 10,000 times more efficient at certain tasks than conventional processors”.

And saving energy is a major advantage of neuromorphic computing since energy consumption typically hinders large scale AI deployments.

Recently, Intel researchers were able to train an AI system to recognize hazardous chemical odors often used to mask the presence of drugs or bombs.

It could detect scents like ammonia, acetone, and methane, even when other smells were used to mask them. Loihi only needed a single sample to learn each odor.

Compare that to the 3,000 samples required to train a state-of-the-art deep learning solution to achieve the same level of classification accuracy.

Clearly, Loihi is set to be a game-changer.

Enduring the Bear Market



And the news comes at an overall good time for Intel. Yes, like other chipmakers it will be negatively impacted by the coronavirus economic shutdown.

But I believe it could come out of this period in better shape than many other leading chip firms.

Let’s start with its most recent quarterly report in which the firm beat on both sales and earnings. For the period ended December 31, earnings rose 19% to $1.52. Sales climbed 8% to $20.2 billion.

Next up is the first-quarter earnings statement that comes out on Thursday. That will give us a sense of how the firm is executing against its plan as well as the impact of Covid-19.

Ironically, Intel got little attention from analysts when it released Pohoiki Springs in mid-March. But Wall Street has taken notice of the firm’s vital role in the global chip industry amid the coronavirus shut down.

Bernstein analyst Stacy Rasgon upgraded Intel’s stock from underperform to market perform – ending his bearish call on the company.

Market Watch quoted Rasgon saying “in a rainstorm the guy with the biggest umbrella usually stays the driest”.

The metaphor alludes to Intel’s strong balance sheet and cheaper valuation, which the analyst believes may give the stock a cushion during the Covid-19 market bear market we’re currently experiencing.

Add it all up and you can see why Intel is a powerful company and its stock should be on your bear market tech watchlist.

This is the kind of stock you can count on for the long haul.

And with a dividend yield of 2.4%, Intel is literally paying you to be patient as the tech leader rebounds from the coronavirus panic.



These are the Top Performing COVID-19 Stocks

These are the Top Performing COVID-19 Stocks

The coronavirus is still rampaging throughout the world.

Businesses and schools are closed.  Stay at home orders have spread across the U.S.  Unemployment has skyrocketed, as the economy grinds to a halt.  What’s worse is – at the moment – there’s no solution. There are no vaccines.

However, we may be getting closer.  

On April 17, 2020, we brought a few of the top vaccine stories to your attention, with many of them picking up a good deal of momentum.

Gilead Sciences Inc. (GILD)

Gilead (GILD) for example is still running on news its vaccine produced “rapid” recovery in patients. In fact, a University of Chicago Phase 3 drug trial found that most of its patients had “rapid recoveries in fever and respiratory symptoms” and were then discharged from the hospital in less than a week, as reported by CNBC.



Moderna Inc. (MRNA)

Moderna Inc. (MRNA) is up another $4.68 on the day after winning an $843 million U.S. award to develop a vaccine.  Moderna hopes to have safety data from Phase 1 trials shortly, which could allow it to advance to the next phase in the second quarter. At the moment, the company is working with the National Institutes of Health on a healthy-volunteer study. Its product is a synthetic strand of messenger RNA (ribonucleic acid), or mRNA (or messenger RNA), designed to convince bodily cells to produce antibodies against the virus.

Inovio Pharmaceuticals (INO)

Inovio Pharmaceuticals (INO) is up 80 cents after starting human trials of its COVID-19 vaccine.

After getting the approval of the U.S. FDA in early April 2020, Inovio vaccine trials began on 40 adult volunteers in Philadelphia and Kansas City. 

Takeda Pharmaceuticals (TAK)

Takeda Pharmaceuticals (TAK) is up slightly as it looks into “whether blood plasma from recovered Covid-19 patients, which can contain infection-fighting antibodies, can be used against the illness. Similar treatments have shown promise in treating other serious infections,” says Bloomberg.



BioNTech (BNTX)

BioNTech (BNTX) is up nearly $4 after receiving  a $185 million upfront payment from Pfizer for a COVID-19 vaccine development collaboration, says MarketWatch.  BNTX could also receive milestone payments of up to $563 million from this, as well.



Road to Recovery: Stock Hotlist for The Week of April 20th, 2020

Road to Recovery: Stock Hotlist for The Week of April 20th, 2020

Markets roared higher last week on news Gilead’s (GILD) coronavirus drug produced “rapid” recovery in patients. In fact, a University of Chicago Phase 3 drug trial found that most of its patients had “rapid recoveries in fever and respiratory symptoms” and were then discharged from the hospital in less than a week, as reported by CNBC.  

“An effective treatment is a huge deal and would create a path to open the economy and resume normal ‘social activities’ way sooner than a vaccine,” said Tom Lee, head of research at Fundstrat Global Advisors, as also quoted by CNBC. “A treatment is safer and more scalable because it is only given to people who need to be treated.”

With 2.17 million global cases, and 146,071 unfortunate deaths, this welcomed news could put us one step closer to finding a solution.

However, Gilead wasn’t the only vaccine stock with big, market-driving news.  

Gilead isn’t the only vaccine stock surging on COVID-19 news, though.



Shares of Moderna (MRNA) are racing higher after winning an $843 million U.S. award to develop a vaccine.  “By investing now in our manufacturing process scale-up to enable large scale production for pandemic response, we believe that we would be able to supply millions of doses per month in 2020 and with further investments, tens of millions per month in 2021, if the vaccine candidate is successful in the clinic,” commented CEO Stéphane Bancel.

As we wait to see what happens next, here are top stocks piquing our interest.

Opportunity No. 1 – Zynga (ZNGA)

As governments around the world encourage social distancing to slow the spread of the coronavirus, video game stocks have been some of the top beneficiaries.  “Videogames could see increased engagement as folks fight off cabin fever. Online gaming often includes voice chat, a way friends can keep in touch and hang out virtually amid self-quarantines. Anecdotally, increased network data from Telecom Italia, suggesting such increased online use in Italy. Plus, as Americans avoid vacations, dining out and attending events, they will have more money to spend on videogames and their digital add-ons,” says Cowen analysts, as quoted by Barron’s.

Opportunity No. 2 — Slack Technologies Inc. (WORK)

Slack is one of the top companies benefiting as people work from home at the moment.  While it hasn’t seen the same upside Zoom Video Communications has seen, it’s still pushing higher.  Cantor Fitzgerald analysts also just covered the stock with an overweight rating. “We believe the company and platform have a number of unique, positive attributes, including its ability to drive customer productivity and efficiency, applicability across all industries and business sizes, and a growing ecosystem to facilitate seamless integration,” notes the firm, as quoted by Barron’s. “We expect these attributes to lead to increased market penetration and margin.”

Opportunity No. 3 – Moderna Inc. (MRNA)With a vaccine under development, as noted above, MRNA could run to $55, near-term.  As reported by FierceBiotech, “If all goes well, Moderna aims to start a phase 2 study of the vaccine in the second quarter, with a phase 3 study that could begin ‘as soon as fall, 2020.’ The company plans to scale up manufacturing of the vaccine this year.”



This is Why Oil Could Drop to $10 Near-Term

0
This is Why Oil Could Drop to $10 Near-Term

The U.S. Energy Secretary says oil may now be at a bottom.

“I think we may be at a floor. I think the intent of this conversation with OPEC and the rest of the G-20 countries is simply to do exactly that, to mitigate,” said U.S. Energy Secretary Dan Brouillette, adding that prices would be much lower if no agreement had been reached.



Unfortunately, we may not be anywhere near a bottom.

Should supply-demand fail to balance out, we could see $10 oil near-term.

For one, there’s far too much supply on the market and no demand.  In fact, oil just dropped under $20 a barrel on fear the biggest production cuts in history won’t be able to offset weak demand.  “Oil demand will this month hit its lowest levels for the year, according to the International Energy Agency, falling 29m barrels a day below last year’s average to levels not seen since 1995,” as reported by The Guardian.

In addition, the world is still flooding the world with oil with the pact yet to begin, says Bloomberg.  “State-owned oil company Saudi Aramco pledged to boost output to 12.3 million barrels a day in April as it slashed prices in a battle for market share, following the collapse of the three-year old OPEC+ pact last month.”

And, according to the U.S. Energy Information Administration, for the week ending April 10 inventory increased by 19.2 million barrels. Analysts were only expecting just over 12 million barrels, reports CNBC.  “There is no feasible agreement that could cut supply by enough to offset such near-term demand losses,” the IEA said in its monthly report. 

The U.S. Energy Secretary can tell us we’re nearing a bottom, but until excess supply is gone, and we see sizable demand for oil, we could see $10 barrel.  Even Goldman Sachs has warned the “historic, but insufficient” deal won’t be enough to help, as reported by The Guardian.



Worse, we’re running out of places to store supply.

It’s gotten so bad some tankers are storing global oil supply at sea. According to President Trump added, We don’t have room to store oil anymore. We are using ships to store it.  There’s never been a glut like this. We have to get rid of this tremendous supply,” as quoted by Forbes.

With all of that in mind, $10 oil is a very real possibility.



Relief money is coming – for some. Here’s what to know.

0
Relief money is coming – for some. Here’s what to know.

Americans are beginning to see the first economic impact payments hit their bank accounts.

The IRS tweeted Saturday that it had begun depositing the funds into taxpayers’ bank accounts and would be working to get them out as fast as possible. The one-time payments were approved by Congress as part of an emergency relief package intended to combat the economic damage from the coronavirus pandemic.

The exact timing of when people get their money depends on a few factors, such as income and payment delivery method.

Here is what you should expect:



WHO IS GETTING A CHECK?

Any adult earning up to $75,000 in adjusted gross income who has a valid Social Security number will receive a $1,200 payment.

The payment steadily declines for those who make more and phases out for those who earn more than $99,000. For married couples, both adults receive $1,200, with the phase-out starting at $150,000 of income and falling to zero for couples who earn $198,000.

Parents will also get payments of $500 for each eligible child; this is generally those 16 years old or younger.

For heads of household with one child, the benefit starts to decline at $112,500 and falls to zero at $136,500.

Even those who only receive Social Security or other government benefit programs can receive a check.

WHO DOESN’T GET ONE?

High-income filers are excluded, as is anyone without a valid Social Security number.



If someone can be claimed as a dependent on someone else’s return, such as an adult child or student, they will not get a payment. Nonresident aliens aren’t eligible. People who filed Form 1040-PR or 1040-SS for 2019 are not eligible; these are IRS forms used for certain types of self-employment income in Puerto Rico.

WHAT DO I HAVE TO DO TO GET ONE?

For most people, nothing.

Checks will arrive via direct deposit if a taxpayer included the relevant information on their tax return filed this year or last.



Some Americans are not required to file a tax return — such as low-income taxpayers, Social Security recipients, some veterans and people with disabilities.

After some back and forth with lawmakers, the Treasury and IRS ultimately decided Social Security recipients and railroad retirees, who aren’t typically required to file taxes, would not need to file a simple tax return to get the payment.

Anyone else who isn’t typically required to file taxes and does not receive Social Security will still need to file an abbreviated return to get the payment. On Friday, the Treasury unveiled an online tool that allows these non-filers to more quickly register to get their check.

If someone didn’t file a tax return for either the 2018 or 2019 tax year, the IRS is urging them to file as soon as they can.

And for people who filed taxes for those years but did not include direct deposit information, the IRS plans to have a “Get My Payment” app available later this week that will allow them to add their bank information so their payment can be deposited.

For everyone else, the government will mail a check.

WHEN WILL I GET THE PAYMENT?



Direct deposits began this weekend. The Treasury said paper checks will begin to be issued later in the month.

Everyone who gets a payment will receive written notice within 15 days after the payment that specifies how much you received and how it was delivered. The IRS also said the “Get My Payment” app will allow taxpayers to track the status of their payment.

A memo from lawmakers earlier in the month said that paper checks wouldn’t start being mailed until May. And because the paper checks would be issued at a rate of about 5 million a week, the process could take through August.

The Treasury, however, said that paper checks payments would begin later in April but did not confirm a date or how long it would take to complete those distributions.

All payments will be made based on income, with lower-income individuals receiving payment first.

WHY SO LONG?

It’s a tough wait for those who are struggling financially.

However, the Treasury and the IRS need to sort through a tremendous amount of data and create a complex distribution method plan quite quickly, said Mark Mazur, director of the nonprofit Tax Policy Center. The IRS’ outdated technology could also slow things down.

“For the vast majority of people this will work, it may not be as fast as they may like but it will work.” Mazur said.

BE AWARE

Additionally, the IRS is urging people to be on the lookout for any scams related to the economic impact payments.

The IRS will not call, text, email or contact people via social media asking for personal or bank account information ever. It also warns taxpayers to watch out for emails with attachments or links claiming to have special information about economic impact payments or refunds.